Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Articles published by Business Wire

< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
SWKS Deadline: Rosen Law Firm Urges Skyworks Solutions, Inc. (NASDAQ: SWKS) Stockholders to Contact the Firm for Information About Their Rights
From The Rosen Law Firm, P.A.
Via Business Wire
Tickers SWKS
Valnet Inc. and its CEO File Lawsuit Against The Wrap News Inc. for Defamation, Unfair Competition and Other Illegal Actions
From Valnet Inc.
Via Business Wire
OLYMPUS Long-Term Follow-Up Study Reports Nearly Four-Year Duration of Response in Subset of Patients with Low-Grade Upper Tract Urothelial Cancer Who Achieved a Complete Response to Initial JELMYTO Treatment
From UroGen Pharma Ltd.
Via Business Wire
Tickers URGN
Phixius by Nacha Expands Bank Account Validation Coverage With ValidiFI
From Nacha
Via Business Wire
New Patient-Reported Outcomes from UGN-102 Clinical Trials Show the Investigational Treatment Did Not Adversely Affect Functionality, Symptom Burden, and Quality of Life in Patients with LG-IR-NMIBC
From UroGen Pharma Ltd.
Via Business Wire
Tickers URGN
New Long-Term Follow-Up Data from OPTIMA II Study of UGN-102 Demonstrates Median Duration of Response of Two Years in Patients with LG-IR-NMIBC
From UroGen Pharma Ltd.
Via Business Wire
Tickers URGN
GERN Deadline: Rosen Law Firm Urges Geron Corporation (NASDAQ: GERN) Stockholders to Contact the Firm for Information About Their Rights
From The Rosen Law Firm, P.A.
Via Business Wire
Tickers GERN
KEYTRUDA® (pembrolizumab) as Perioperative Treatment With Standard of Care (SOC) Adjuvant Therapy Significantly Improved Event-Free Survival Compared to SOC Alone in Patients With Resectable Locally Advanced Head and Neck Squamous Cell Carcinoma
From Merck & Co., Inc.
Via Business Wire
Tickers MRK
FLNC Deadline: Rosen Law Firm Urges Fluence Energy, Inc. (NASDAQ: FLNC) Stockholders to Contact the Firm for Information About Their Rights
From The Rosen Law Firm, P.A.
Via Business Wire
Tickers FLNC
RC Deadline: Rosen Law Firm Urges Ready Capital Corporation (NYSE: RC) Stockholders to Contact the Firm for Information About Their Rights
From The Rosen Law Firm, P.A.
Via Business Wire
Tickers RC
Lead Plaintiff Deadline on May 12, 2025 for GERN Investors - Kessler Topaz Meltzer & Check, LLP Encourages Investors with Losses to Contact the Firm
From Kessler Topaz Meltzer & Check, LLP
Via Business Wire
Tickers GERN
Swimlane Ranks ‘Most Valuable Pioneer’ in SecOps AI
From Swimlane
Via Business Wire
MRVI Deadline: Rosen Law Firm Urges Maravai Lifesciences Holdings, Inc. (NASDAQ: MRVI) Stockholders to Contact the Firm for Information About Their Rights
From The Rosen Law Firm, P.A.
Via Business Wire
Tickers MRVI
TFII Deadline: Rosen Law Firm Urges TFI International Inc. (NYSE: TFII) Stockholders to Contact the Firm for Information About Their Rights
From The Rosen Law Firm, P.A.
Via Business Wire
Tickers TFII
RKLB Deadline: Rosen Law Firm Urges Rocket Lab USA, Inc. (NASDAQ: RKLB) Stockholders to Contact the Firm for Information About Their Rights
From Rosen Law Firm
Via Business Wire
Tickers RKLB
ELF Deadline: Rosen Law Firm Urges e.l.f. Beauty, Inc. (NYSE: ELF) Stockholders to Contact the Firm for Information About Their Rights
From The Rosen Law Firm, P.A.
Via Business Wire
Tickers ELF
QUBT Deadline: Rosen Law Firm Urges Quantum Computing Inc. (NASDAQ: QUBT) Stockholders to Contact the Firm for Information About Their Rights
From The Rosen Law Firm, P.A.
Via Business Wire
Tickers QUBT
Innorna Announces FDA Rare Pediatric Disease and Orphan Drug Designations Granted to IN013 for Treatment of Wilson Disease
From Innorna Co. Ltd.
Via Business Wire
EyeMD EMR Healthcare Systems, Inc., a Leading Healthcare Technology Provider for Ophthalmologists, Announces Significant Growth Investment from Performant Capital
From Performant Capital
Via Business Wire
UroGen Announces Updated 18-Month Duration of Response (DOR) of 80.6% from the Phase 3 ENVISION Trial of UGN-102, an Investigational Treatment for Recurrent Low-Grade Intermediate-Risk Non-Muscle Invasive Bladder Cancer (LG-IR-NMIBC)
From UroGen Pharma Ltd.
Via Business Wire
Tickers URGN
Pfizer’s Sasanlimab Combination Significantly Improves Event-Free Survival in BCG-Naïve, High-Risk Non-Muscle Invasive Bladder Cancer
From Pfizer Inc.
Via Business Wire
Tickers PFE
NSSC Investors Have Opportunity to Lead Napco Security Technologies, Inc. Securities Fraud Lawsuit with the Schall Law Firm
From The Schall Law Firm
Via Business Wire
Tickers NSSC
UroGen Pharma Announces Encouraging Results from a Phase 1 Dose-Escalation Study Evaluating UGN-301 in Non-Muscle Invasive Bladder Cancer
From UroGen Pharma Ltd.
Via Business Wire
Tickers URGN
Diamond Comic Distributors Announces Change in Acquisition Partners
From Diamond Comic Distributors
Via Business Wire
CORRECTING and REPLACING EyeCare Partners Presents Latest Innovations in Eye Care at the American Society of Cataract and Refractive Surgery (ASCRS) 2025 in Los Angeles
From EyeCare Partners
Via Business Wire
US Metro Bancorp Announces First Quarter 2025 Results
From US Metro Bancorp
Via Business Wire
Tickers USMT
Marti Technologies, Inc. to Report Full Year 2024 Results on April 29, 2025
From Marti Technologies, Inc.
Via Business Wire
Tickers MRT
Resecurity to Exhibit at MILIPOL India 2025 to Accelerate Defense Innovations
From Resecurity
Via Business Wire
Deadline Soon: Quantum Computing Inc. (QUBT) Investors Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz About Securities Fraud Lawsuit
From The Law Offices of Frank R. Cruz
Via Business Wire
Tickers QUBT
Visual Matrix Expands in the Middle East, Partnering With the Best Western Premier M Four Hotel in Dubai to Provide Advanced Property Management Solutions
From Visual Matrix
Via Business Wire
< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.